Author links open overlay panel F. Rozet ab, C. Hennequin ac, J.-B. Beauval ad, P.
Beuzeboc ae, L. Cormier af, G. Fromont-Hankard ag, P. Mongiat-Artus ah, G. Ploussard ai …

Background The optimal duration of androgen suppression for men with locally advanced
prostate cancer receiving radiotherapy with curative intent is yet to be defined. Zoledronic …

Historically, the treatment of prostate cancer has required little anatomic information beyond
the location of the prostate gland and adjacent seminal vesicles. Radiation therapy has …

Purpose To clarify the relative effects of duration of androgen suppression (AS) and
radiation dose escalation (RDE) on distant progression (DP) in men with locally advanced …

Purpose We assessed the association of the spatial distribution of dose to the bladder
surface, described using dose-surface maps, with the risk of urinary dysfunction. Methods …

In 2014 a consensus conference convened by the International Society of Urological
Pathology (ISUP) adopted amendments to the criteria for Gleason grading and scoring (GS) …

Purpose: Given the paucity of available data concerning radiotherapy‐induced urinary
toxicity, it is important to ensure derivation of the most robust models with superior predictive …

Background It remains unclear whether eradication of oligometastases by stereotactic body
radiation therapy or other means will result in cure or prolongation of survival in some cases …

Aims Perineural invasion (PNI) by prostatic adenocarcinoma is debated as a prognostic
parameter. This study investigates the prognostic predictive value of PNI in a series of …

Purpose Prostate brachytherapy (PB) has well-documented excellent long-term outcomes in
all risk groups. There are significant uncertainties regarding the role of androgen deprivation …